Primary sjögren’s syndrome and cardiovascular disease
Ημερομηνία
2020Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Sjögren’s syndrome is a rheumatic autoimmune disease that primarily affects middle-aged women and runs a slowly progressing course with sicca symptoms being the prevalent manifestation. Premature atherosclerosis and increased cardiovascular (CV) morbidity and mortality are frequently encountered in rheumatic diseases characterized by significant systemic inflammation, such as the inflammatory arthritides, systemic vasculitides and systemic lupus erythematosus. In the same context, chronic inflammation and immune aberrations underlying Sjögren’s syndrome are also reported to be associated with augmented risk of atherosclerosis. Increased CV disease (CVD) frequency has been found in recent meta-analyses. The involvement of the CV system is not a common feature of Sjögren’s0 syndrome; however, specific manifestations, such as autoantibody-mediated heart block, pericarditis, pulmonary arterial hypertension and dysautonomia, have been described. This review focuses on studies addressing CV morbidity in Sjögren’s syndrome and presents current data regarding distinct CV fea-tures of the disease. © 2020 Bentham Science Publishers.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Bahls M., Lorenz M.W., Dörr M., Gao L., Kitagawa K., Tuomainen T.-P., Agewall S., Berenson G., Catapano A.L., Norata G.D., Bots M.L., van Gilst W., Asselbergs F.W., Brouwers F.P., Uthoff H., Sander D., Poppert H., Hecht Olsen M., Empana J.P., Schminke U., Baldassarre D., Veglia F., Franco O.H., Kavousi M., de Groot E., Mathiesen E.B., Grigore L., Polak J.F., Rundek T., Stehouwer C.D.A., Skilton M.R., Hatzitolios A.I., Savopoulos C., Ntaios G., Plichart M., McLachlan S., Lind L., Willeit P., Steinmetz H., Desvarieux M., Ikram M.A., Johnsen S.H., Schmidt C., Willeit J., Ducimetiere P., Price J.F., Bergström G., Kauhanen J., Kiechl S., Sitzer M., Bickel H., Sacco R.L., Hofman A., Völzke H., Thompson S.G., on behalf of the PROG-IMT Study Group (2020)Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for ... -
Exercise intervention on cardiorespiratory fitness in rheumatoid arthritis patients with high cardiovascular disease risk: a single-arm pilot study
Sobejana M., van den Hoek J., Metsios G.S., Kitas G.D., van der Leeden M., Verberne S., Jorstad H.T., Pijnappels M., Lems W.F., Nurmohamed M.T., van der Esch M. (2022)Objective: In patients with rheumatoid arthritis (RA) with cardiovascular disease risk, it is unknown whether exercises are safe, improve cardiorespiratory fitness and reduce disease-related symptoms and cardiovascular-disease ... -
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
Tsatsakis A., Calina D., Falzone L., Petrakis D., Mitrut R., Siokas V., Pennisi M., Lanza G., Libra M., Doukas S.G., Doukas P.G., Kavali L., Bukhari A., Gadiparthi C., Vageli D.P., Kofteridis D.P., Spandidos D.A., Paoliello M.M.B., Aschner M., Docea A.O. (2020)Common manifestations of COVID-19 are respiratory and can extend from mild symptoms to severe acute respiratory distress. The severity of the illness can also extend from mild disease to life-threatening acute respiratory ...